Related references
Note: Only part of the references are listed.microRNAs and Esophageal Cancer - Implications for Pathogenesis and Therapy
George C. Mayne et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
Matthew S. Davids et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma
Niamh Lynam-Lennon et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
MicroRNA and its roles in esophageal cancer
Yu Fang et al.
MEDICAL SCIENCE MONITOR (2012)
Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
Rie Hamano et al.
CLINICAL CANCER RESEARCH (2011)
MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab
Naohiro Nishida et al.
CLINICAL CANCER RESEARCH (2011)
Is the Epithelial-to-Mesenchymal Transition Clinically Relevant for the Cancer Patient?
Martin A. Krasnapolski et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Mir-148a Improves Response to Chemotherapy in Sensitive and Resistant Oesophageal Adenocarcinoma and Squamous Cell Carcinoma Cells
Richard Hummel et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
Katrin M. Sjoquist et al.
LANCET ONCOLOGY (2011)
The Prognostic and Chemotherapeutic Value of miR-296 in Esophageal Squamous Cell Carcinoma
Liu Hong et al.
ANNALS OF SURGERY (2010)
Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer
Vicky S. Sabine et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa
M. T. de Bruijn et al.
BRITISH JOURNAL OF CANCER (2010)
Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma
Hongwei Zhang et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
Richard Hummel et al.
EUROPEAN JOURNAL OF CANCER (2010)
miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation
Valentina Boni et al.
MOLECULAR CANCER THERAPEUTICS (2010)
DIANA-mirPath: Integrating human and mouse microRNAs in pathways
G. L. Papadopoulos et al.
BIOINFORMATICS (2009)
MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma
Yukiharu Hiyoshi et al.
CLINICAL CANCER RESEARCH (2009)
Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells
Ye Zhang et al.
JOURNAL OF PATHOLOGY (2009)
Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development
Shu-Feng Zhou et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells
Monica Lopez-Guerra et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
Val Gebski et al.
LANCET ONCOLOGY (2007)
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents
J Ren et al.
CANCER CELL (2004)
Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3
XM Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)